Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile

Novel arylsulfonamides were identified as high-affinity dopamine D3 and D2 receptor ligands. Some derivatives were found to be active in antipsychotic tests in vivo. A novel series of arylsulfonamides was prepared either by automated parallel or by traditional solution-phase synthesis. Several membe...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters Vol. 17; no. 19; pp. 5340 - 5344
Main Authors: Ágai-Csongor, Éva, Nógrádi, Katalin, Galambos, János, Vágó, István, Bielik, Attila, Magdó, Ildikó, Ignácz-Szendrei, Györgyi, Keserű, György Miklós, Greiner, István, Laszlovszky, István, Béla Kiss, Éva Schmidt, Judit Laszy, Katalin Sághy, Gyertyán, István, Zájer-Balázs, Mária, Gémesi, Larisza, Domány, György
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 01-10-2007
Elsevier
Subjects:
Rat
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Novel arylsulfonamides were identified as high-affinity dopamine D3 and D2 receptor ligands. Some derivatives were found to be active in antipsychotic tests in vivo. A novel series of arylsulfonamides was prepared either by automated parallel or by traditional solution-phase synthesis. Several members of this compound library were identified as high-affinity dopamine D3 and D2 receptor ligands. The most interesting representative, compound 2, showed potent antipsychotic behaviour coupled with a beneficial cognitive and EPS profile.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2007.08.015